The disposition and metabolism of the synthetic prostaglandin fluprostenol (ICI 81,008) in the horse. 1980

D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons

1. Following single intramuscular doses of [14C]fluprostenol (0.5--2.4 micrograms/kg) to three female horses and to three gelded male horses, radioactivity was present in the plasma within 5 min; peak concn. (0.32--1.30 ng/ml fluprostenol equiv.) occurred 5 to 90 min after injection. Radioactivity was still present in the plasma of the females after three days. About 88% of fluprostenol is bound to plasma proteins. 2. Radioactivity was present in the parotid saliva of the gelded male horses within 10 min. Peak concn. (45--91 pg/ml fluprostenol equiv.) occurred from 5 min to 1 h after injection. Saliva : plasma concn. ratios varied inversely with saliva flow rate and limiting ratios were 0.33 and 0.41 for the combined results of two experiments on each of two male horses; the calculated value is 0.46 Chromatography indicated that the majority of plasma and saliva radioactivity was [14C]fluprostenol. 3. Excretion of radioactivity in the urine was rapid and virtually complete 12 h after dosing. The total radioactivity excreted in urine by the female horses was 45% of the dose (96 h) and by the gelded male horses 53% (30 h). About 30% of the radioactivity present in the urines was unchanged fluprostenol. 4. Faecal excretion, which was substantially complete after 2 days, accounted for 32% of the radioactivity administered to the female horses. 5. Tissue conc. of radioactivity in the female horses at four days were below the limits of detection (90 pg/g), but 0.2--0.9% of the dose was detected at the site of injection.

UI MeSH Term Description Entries
D008186 Luteolytic Agents Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. Luteolytic Agent,Luteolytic Effect,Luteolytic Effects,Agent, Luteolytic,Agents, Luteolytic,Effect, Luteolytic,Effects, Luteolytic
D011461 Prostaglandins F, Synthetic Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF. PGF Synthetic,Prostaglandin F Analogs,Prostaglandin F Analogues,Synthetic Prostaglandins F,Analogs, Prostaglandin F,Analogues, Prostaglandin F,Synthetic, PGF
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas

Related Publications

D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
July 1976, The Veterinary record,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
January 1979, Journal of reproduction and fertility. Supplement,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
January 1977, Tierarztliche Praxis,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
January 1981, Proceedings of the Western Pharmacology Society,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
March 1979, Prostaglandins and medicine,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
July 1974, Prostaglandins,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
July 1974, New Zealand veterinary journal,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
October 1979, Xenobiotica; the fate of foreign compounds in biological systems,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
January 1987, Drug metabolism reviews,
D I Chapman, and M S Moss, and P W Tomlinson, and M P Harrison, and P J Simmons
September 1993, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!